Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid JL, Rodicio J, Safar M, Eckes L, Rizzini P; European Lacidipine Study on Atherosclerosis investigators. Zanchetti A, et al. Among authors: hennig m. Circulation. 2002 Nov 5;106(19):2422-7. doi: 10.1161/01.cir.0000039288.86470.dd. Circulation. 2002. PMID: 12417537 Clinical Trial.
Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA).
Zanchetti A, Bond MG, Hennig M, Tang R, Hollweck R, Mancia G, Eckes L, Micheli D; ELSA Investigators. Zanchetti A, et al. Among authors: hennig m. J Hypertens. 2004 Jun;22(6):1201-12. doi: 10.1097/00004872-200406000-00022. J Hypertens. 2004. PMID: 15167456 Clinical Trial.
Different relation between 24-h blood pressure and distensibility at different peripheral arteries. Data from the European Lacidipine Study on Atherosclerosis (ELSA).
Giannattasio C, Failla M, Hennig M, Hollweck R, Laurent S, Mallion JM, Reid J, Safar M, Bond G, Zanchetti A, Mancia G. Giannattasio C, et al. Among authors: hennig m. J Hypertens. 2005 Mar;23(3):557-62. doi: 10.1097/01.hjh.0000160212.33232.3e. J Hypertens. 2005. PMID: 15716697 Clinical Trial.
Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA).
Zanchetti A, Hennig M, Hollweck R, Bond G, Tang R, Cuspidi C, Parati G, Facchetti R, Mancia G. Zanchetti A, et al. Among authors: hennig m. Circulation. 2009 Sep 22;120(12):1084-90. doi: 10.1161/CIRCULATIONAHA.108.773119. Epub 2009 Sep 8. Circulation. 2009. PMID: 19738145
Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis.
Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid J, Rodicio J, Safar M, Eckes L, Ravinetto R. Zanchetti A, et al. Among authors: hennig m. J Hypertens. 1998 Jul;16(7):949-61. doi: 10.1097/00004872-199816070-00008. J Hypertens. 1998. PMID: 9794735 Clinical Trial.
Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA).
Agabiti-Rosei E, Trimarco B, Muiesan ML, Reid J, Salvetti A, Tang R, Hennig M, Baurecht H, Parati G, Mancia G, Zanchetti A; ELSA Echocardiographic Substudy Group. Agabiti-Rosei E, et al. Among authors: hennig m. J Hypertens. 2005 May;23(5):1091-8. doi: 10.1097/01.hjh.0000166852.18463.5e. J Hypertens. 2005. PMID: 15834297 Clinical Trial.
309 results